Track topics on Twitter Track topics that are important to you
LONDON (Reuters) - GlaxoSmithKline has appointed Hal Barron, research head at Alphabet-funded Calico, as its new president of R&D, replacing Patrick Vallance, who will take up a top science job for the British government, the company said on Wednesda...
Original Article: GSK nabs Calico scientist Barron as new R&D head, Vallance quitsNEXT ARTICLE
GlaxoSmithKline is the third largest pharmaceutical company in the world, based on annual sales, which reached $37,134m in 2009. Spread over 100 countries, GSK employs 96,500 people, 13,000 of which are dedicated to research and development of the the ...